11 results
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
bleeding, Prevention ... of variceal rebleeding ... gastropathy • Dosing ... hepatology #management #pharmacology ... #indications #dosing
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
lead to severe bleeding ... management #algorithm #pharmacology ... #medications #table ... #decisionaid #cardiology ... #dosing
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Diuretics #Pharmacology ... #Comparison #Table ... #HalfLife #Dosing ... Thiazide #CHF #Cardiology
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Beta Blockers - Pharmacology ... Comparison Table ... Migraine prophylaxis, Variceal ... Beta #Blockers #Pharmacology ... #Receptors #cardiology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
palmetto - Increases bleeding ... Bilberry, Danshen, Dong ... palmetto - Increases bleeding ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
REBEL Review 90: Weight Based 4 Factor PCC Dosing 

#Hematology #Management #Table #4FactorPCC #REBELReview #Pharmacology #Dosing
Based 4 Factor PCC Dosing ... #Hematology ... #Management #Table ... #REBELReview #Pharmacology ... #Dosing #WeightBased
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
clearance (calculated using ... per treatment table ... and procedural bleeding ... with a very low bleeding ... Management #Treatment #pharmacology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
DOACs thereby leading ... metabolization leading ... Chemotherapy #Oncology #Hematology ... #Interactions #Table ... #Pharmacology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... Transient K+ efflux moving ... inotropy) ACCP Cardiology ... Antiarrhythmics #Pharmacology ... pathophysiology #phases #cardiology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Management during ... Management during ... Delivery • Stable ... Period • Breast-feeding ... diagnosis #management #cardiology